10/16/2025 17:58
Beyon Cyber and Haven Sign MoU to Launch Advanced AI-Powered SOC Capabilities in the UK and Worldwide

Beyon Cyber, part of the Beyon Group and the fastest growing cyber security company in the Middle East, has signed a Memorandum of Understanding (MoU) with Haven Cyber Technologies, a global cyber security services provider and a Microsoft Solutions Partner, through its UK-based subsidiary ITC Secure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251016047852/en/Beyon Cyber and Haven Sign MoU Under the MoU, Beyon Cyber and Haven wi...

10/16/2025 21:00
Kinaxis Inc. to Host Third Quarter 2025 Financial Results Conference Call on November 6, 2025

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its third quarter ended September 30, 2025. The call will be hosted on Thursday, November 6 at 8:30 a.m. Eastern Time by Bob Courteau, interim chief executive officer and chair, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the...

10/16/2025 23:00
Bentley Systems Announces Winners of the 2025 Going Digital Awards

(Bentley Systems’ Year in Infrastructure 2025) – Bentley Systems, Incorporated (Nasdaq: BSY), the infrastructure engineering software company, today announced the winners of the 2025 Going Digital Awards. The annual awards honor the extraordinary work of infrastructure professionals and their innovative use of Bentley software to improve the way infrastructure is designed, built, and operated. This press release features multimedia. View the full release here: https://www.businesswire.com/news...

10/17/2025 00:42
Dompé's Program in NAION Selected for Landmark FDA Commissioner’s National Priority Voucher Program

Dompé, a leading biopharmaceutical company with operations in Italy and the US, announced today its selection by the United States Food and Drug Administration (FDA) to participate in the Commissioner’s National Priority Voucher (CNPV) program. Because of its selection, Dompé has been awarded a voucher granting a significantly shortened review timeline for marketing application and enhanced collaboration with the FDA. Dompé intends to apply the voucher for the Biologic License Application (BLA)...

10/17/2025 06:24
Cinemo CARS™ Connect Direct Named 2025 Automotive Infotainment Solution of the Year by AutoTech Breakthrough

Cinemo, a global leader and highly innovative one-stop-shop provider for fully integrated digital media products, today announced that CARS Connect Direct has been named “Automotive Infotainment Solution of the Year” in the sixth annual AutoTech Breakthrough Awards program conducted by AutoTech Breakthrough, a leading market intelligence organization that recognizes the most innovative companies and technologies transforming the automotive industry. This press release features multimedia. View...

10/17/2025 11:00
Kinaxis Accelerates Agentic Era for Supply Chain Orchestration with the Launch of Maestro Agents

Kinaxis® Inc. (TSX: KXS), a global leader in supply chain orchestration, today announced Maestro Agents, marking the next milestone in AI-enabled decision intelligence for supply chains. Now available to Kinaxis customers and embedded natively in Kinaxis Maestro®, these AI-powered context aware digital co-workers help planners move faster from issue to action, turning disruption into opportunity, and strengthening the resilience of the supply chains that power the global economy. “Kinaxis age...

10/17/2025 12:15
Avanzanite Bioscience’s Partner Agios Announces Positive CHMP Opinion for PYRUKYND® (mitapivat) for Adults with Thalassemia

Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a pos...

10/17/2025 13:04
Vertex Announces Progress in Povetacicept Development Program and Presentation of New Data at American Society of Nephrology Kidney Week

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced several important updates across its development program for povetacicept (pove), an investigational recombinant fusion protein therapeutic and dual antagonist of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines. Pove has demonstrated best-in-class potential in IgA nephropathy (IgAN) and primary membranous nephropathy (pMN) and has pipeline-in-a-product potential across a range of B cell-...